Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Melanoma × TP protocol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Esophageal Neoplasms 4 Esophageal Squamous Cell Carcinoma 3 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Recurrence 1 Neoplasm Metastasis 1 Melanoma 1 Lymphatic Metastasis 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Dacarbazine 22 Nivolumab 20 pembrolizumab 15 Ipilimumab 15 Interferon-alpha 10 trametinib 7 aldesleukin 7 dabrafenib 6 Vemurafenib 6 Temozolomide 6 Introns 6 Interferon alpha-2 6 Interleukin-2 5 Cisplatin 5 Radiotherapy 4 Chemotherapy, Adjuvant 4 cobimetinib 3 cemiplimab 3 binimetinib 3 Vinblastine 3 Specimen Handling 3 Sodium Chloride 3 Radiosurgery 3 Paclitaxel 3 Opdualag 3 Melphalan 3 Magnetic Resonance Spectroscopy 3 CTLA-4 Antigen 3 technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 2 spartalizumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00779714 2008-10-24

ChemoSensMM

University of Wuerzburg

Phase 3 Unknown

Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡